Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc G Ghany

Showing results (151-160 of 182) with videos related to

Pageof 19
Sort By:
Gastroenterology|November 15, 2006
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis CHerbert L Bonkovsky, Deepa Naishadham, Richard W Lambrecht, et al.
Hepatology (Baltimore, Md.)|June 22, 2010
Outcome of sustained virological responders with histologically advanced chronic hepatitis CTimothy R Morgan, Marc G Ghany, Hae-Young Kim, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2025
Immigration Factors and Monitoring of Chronic Hepatitis B Infection Among Foreign-Born: The FOCUS-HBV Multicentre CohortKali Zhou, Ariel Lee, Christopher Wong, et al.
Gut|April 24, 2026
Differential intrahepatic integrated HBV DNA patterns between HBeAg-positive and HBeAg-negative chronic hepatitis BDaryl T-Y Lau, Elena S Kim, Zhili Wang, et al.
Hepatology (Baltimore, Md.)|June 11, 2024
Reply: The exact predictive value of HBcrAg and HBV RNA in serological status and disease activity in CHBMarc G Ghany, Wendy C King, Amanda S Hinerman, et al.
Gastroenterology|March 23, 2010
Ribavirin improves early responses to peginterferon through improved interferon signalingJordan J Feld, Glen A Lutchman, Theo Heller, et al.
Gastroenterology|December 7, 2010
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis CAnna S Lok, James E Everhart, Elizabeth C Wright, et al.
Gastrointestinal Endoscopy|December 5, 2006
The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosisArun J Sanyal, Robert J Fontana, Adrian M Di Bisceglie, et al.
Hepatology (Baltimore, Md.)|March 18, 2009
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trialAnna S Lok, James E Everhart, Raymond T Chung, et al.
The New England Journal of Medicine|December 5, 2008
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferonAdrian M Di Bisceglie, Mitchell L Shiffman, Gregory T Everson, et al.
Pageof 19

Showing results (151-160 of 182) with videos related to

Sort By:
Pageof 19
Gastroenterology|November 15, 2006
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis CHerbert L Bonkovsky, Deepa Naishadham, Richard W Lambrecht, et al.
Hepatology (Baltimore, Md.)|June 22, 2010
Outcome of sustained virological responders with histologically advanced chronic hepatitis CTimothy R Morgan, Marc G Ghany, Hae-Young Kim, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2025
Immigration Factors and Monitoring of Chronic Hepatitis B Infection Among Foreign-Born: The FOCUS-HBV Multicentre CohortKali Zhou, Ariel Lee, Christopher Wong, et al.
Gut|April 24, 2026
Differential intrahepatic integrated HBV DNA patterns between HBeAg-positive and HBeAg-negative chronic hepatitis BDaryl T-Y Lau, Elena S Kim, Zhili Wang, et al.
Hepatology (Baltimore, Md.)|June 11, 2024
Reply: The exact predictive value of HBcrAg and HBV RNA in serological status and disease activity in CHBMarc G Ghany, Wendy C King, Amanda S Hinerman, et al.
Gastroenterology|March 23, 2010
Ribavirin improves early responses to peginterferon through improved interferon signalingJordan J Feld, Glen A Lutchman, Theo Heller, et al.
Gastroenterology|December 7, 2010
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis CAnna S Lok, James E Everhart, Elizabeth C Wright, et al.
Gastrointestinal Endoscopy|December 5, 2006
The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosisArun J Sanyal, Robert J Fontana, Adrian M Di Bisceglie, et al.
Hepatology (Baltimore, Md.)|March 18, 2009
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trialAnna S Lok, James E Everhart, Raymond T Chung, et al.
The New England Journal of Medicine|December 5, 2008
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferonAdrian M Di Bisceglie, Mitchell L Shiffman, Gregory T Everson, et al.
Pageof 19